Blood Test Shows Obesity Speeds Alzheimer's Development

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs). BBM values increased up to 95% faster in individuals with obesity than in ...

Obesity Could Speed Alzheimer's Progression, Study Suggests

Results showed that people with obesity had blood biomarkers for Alzheimer’s that rose more rapidly, including: Tau proteins, ...
The News International

AI-powered blood tests spots rare eye cancer earlier than standard methods

A major breakthrough has been made that a simple blood test analyzed by artificial intelligence could allow for early ...

DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio

“With DoctorBox, we are gaining a strong partner that enables us to offer ColoAlert exactly where prevention can take place ...

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology

New Peer-Reviewed Publication Highlights Phase 2 SPRING Trial Data Supporting the Disease Modifying Potential of Nebokitugin PSC and Supports ...
Santé log

CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)

Data demonstrates neflamapimod treatment led to significant reductions in plasma glial fibrillary acidic protein ( GFAP), a key marker of neuroinflammation-associated neurodegeneration, and increased ...